Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Morphotek®, Inc., a subsidiary of Eisai Inc., has announced the launch of its Antibody Drug Conjugate (ADC) Services business based on its proprietary REsidue-SPEcific Conjugation TechnologyTM (RESPECTTM) and eribulin-linker toxin platforms.
read more
Wednesday, April 05, 2017
Sharp Clinical Services, part of UDG Healthcare plc, has announced a £9 million investment to fund a new multiple-phase pharmaceutical manufacturing, packaging and distribution facility in Wales.
read more
Wednesday, April 05, 2017
ConverGene has entered into a Collaborative Research and Development Agreement (CRADA) with the Molecular Neuropharmacology Section (MNS) of The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health.
read more
Wednesday, April 05, 2017
JHL Biotech Inc. announced that its Clinical Trial Application ("CTA") for use of JHL1101 in Phase 1 and Phase 3 clinical trials in Non-Hodgkin's Lymphoma patients has been accepted by the China Food and Drug Administration ("CFDA") (filing code: ...
read more
Wednesday, April 05, 2017
Heptares Therapeutics , a wholly owned subsidiary of Sosei Group Corporation, has achieved an important milestone in its immuno-oncology collaboration with AstraZeneca, which is focused on the development of AZD4635 (HTL-1071) as a potential new ...
read more
Ajinomoto Althea is appointing Dr. Lori McDonald as Vice President of Compliance at Althea. Althea's contract manufacturing business continues to grow at a rapid rate driven by biotech companies outsourcing aseptic fill and finish parenteral ...
read more
ABL, a global contract research and manufacturing service provider to the U.S. Government and biopharmaceutical industry, has been awarded a five-year, indefinite delivery/indefinite quantity (ID/IQ) contract #HHSO100201600019I entitled “Respiratory ...
read more
Jonathan Goldman, CEO of Aptuit LLC, announced that Henning Steinhagen, PhD, has been named as President, Research and Development Operations. Henning will continue in his existing role of Site-Head at Aptuit, Verona, Italy whilst assuming oversight...
read more
Accenture will work with BioCelerate, a subsidiary of TransCelerate BioPharma Inc., a nonprofit focused on improving efficiencies in research and development, to develop a platform enabling its member companies to aggregate and analyze preclinical ...
read more
Chubb has expanded its global clinical trial liability insurance coverage for institutional research organizations such as hospitals and medical centers, universities and colleges, research institutes, patient/disease advocacy organizations and ...
read more
PatientsLikeMe and Shire have announced a new collaboration that will support the development of a patient-centered, real world health learning system that expands understanding of patient health and disease.
read more
DiscoverX Corporation, a supplier of innovative cell-based assays and services for drug discovery and development, today announced their partnership with B'SYS GmbH to expand DiscoverX's SAFETYscan in vitro pharmacological profiling services for ion ...
read more
Ferring Pharmaceuticals and Alrise Biosystems announced that the companies have entered into a development agreement with exclusive option rights for Ferring to leverage Alrise’s ImSus®Technology Platform for the development of an injectable, ...
read more
ATUM (formerly DNA2.0) has announced an expansion of its services to include cell line development, which has been enabled by the company's proprietary Leap-In Transposase genome engineering tools. ATUM has also begun construction of a new, 7,000 SF...
read more
SDC, a specialized data services Contract Research Organization (CRO) providing scalable clinical trial solutions, has opened a new office in Waltham, Mass. Fueled by accelerated growth and continued high demand for its services, SDC’s strategic ...
read more